Mouse models of type I interferonopathies
Mouse models of type I interferonopathies
Dokument öffnen (1.1MB)Datum der Veröffentlichung
16.12.2024Verlag / herausgebende Einrichtung
Oxford University PressVerlagsort
OxfordMetadaten
Zur Langanzeige
Zitierbarer Link (Handle URI) 
https://hdl.handle.net/20.500.11811/13361
Inhalt
Type I interferonopathies are severe monogenic diseases caused by mutations that result in chronically upregulated production of type I interferon. They present with a broad variety of symptoms, the mechanisms of which are being extensively studied. Mouse models of type I interferonopathies are an important resource for this purpose, and in this context, we review several key molecular and phenotypic findings that are advancing our understanding of the respective diseases. We focus on genotypes related to nucleic acid metabolism, sensing by cytosolic receptors and downstream signalling.
Schlagwörter
Innate immunity, Innate sensors, Type I interferon, Autoimmunity
Klassifikation (DDC)
570 Biowissenschaften, Biologie 610 Medizin, GesundheitErschienen in
Human Molecular Genetics, 2024, ddae187, S. 1-9Erstpublikation
https://doi.org/10.1093/hmg/ddae187Luca, Domnica; Kato, Hiroki: Mouse models of type I interferonopathies. In: Human Molecular Genetics. 2024, ddae187, 1-9.
Online-Ausgabe in bonndoc: https://hdl.handle.net/20.500.11811/13361
Online-Ausgabe in bonndoc: https://hdl.handle.net/20.500.11811/13361
@article{handle:20.500.11811/13361,
author = {{Domnica Luca} and {Hiroki Kato}},
title = {Mouse models of type I interferonopathies},
publisher = {Oxford University Press},
year = 2024,
month = dec,
journal = {Human Molecular Genetics},
volume = 2024, ddae187,
pages = 1--9,
note = {Type I interferonopathies are severe monogenic diseases caused by mutations that result in chronically upregulated production of type I interferon. They present with a broad variety of symptoms, the mechanisms of which are being extensively studied. Mouse models of type I interferonopathies are an important resource for this purpose, and in this context, we review several key molecular and phenotypic findings that are advancing our understanding of the respective diseases. We focus on genotypes related to nucleic acid metabolism, sensing by cytosolic receptors and downstream signalling.},
url = {https://hdl.handle.net/20.500.11811/13361}
}
author = {{Domnica Luca} and {Hiroki Kato}},
title = {Mouse models of type I interferonopathies},
publisher = {Oxford University Press},
year = 2024,
month = dec,
journal = {Human Molecular Genetics},
volume = 2024, ddae187,
pages = 1--9,
note = {Type I interferonopathies are severe monogenic diseases caused by mutations that result in chronically upregulated production of type I interferon. They present with a broad variety of symptoms, the mechanisms of which are being extensively studied. Mouse models of type I interferonopathies are an important resource for this purpose, and in this context, we review several key molecular and phenotypic findings that are advancing our understanding of the respective diseases. We focus on genotypes related to nucleic acid metabolism, sensing by cytosolic receptors and downstream signalling.},
url = {https://hdl.handle.net/20.500.11811/13361}
}
Die folgenden Nutzungsbestimmungen sind mit dieser Ressource verbunden:
